CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 50 enrolled
Drug / intervention
Botoxdrug
Likely dose
Botox 4 unitsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00856999
NCT00856999Phase 4Completed
CompareCT.gov

Botox Cosmetic and the Young Patient With Glabellar Furrows

Oregon Health and Science University·interventional·Posted Mar 6, 2009·Updated Jul 23, 2019

In Brief

A Phase 4 clinical trial evaluating Botox for Glabellar Furrows. Completed, enrolled 50 participants.

Detailed Summary

The purpose of this study is to see if consistent treatment with Botox will lead to longer lasting effects. Botox is an injectable liquid that is approved by the U.S. Food and Drug Administration to reduce wrinkles on the forehead in the area between the eyebrows. In this study a different dosing schedule of Botox injections will be used to see if the effects of the Botox treatment last longer than the effects of the standard injection regimen.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlabellar Furrows
Countries--
CollaboratorsAllergan

Timeline

Phase 4CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 6, 2009
Enrollment StartFeb 8, 2005
Primary CompletionNov 17, 2010
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 17.3 years ago

Interventions

Botoxdrug

Botox Cosmetic will be delivered in standard doses of 4 units per injection site over a total of 5 sites, thus treating the procerus and corrugator superciliaris muscle groups